Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

English (EN)·Polski (PL)·Ukraiński (UK)
Go to the home page of the library Uniwersytet Ekonomiczny we Wrocławiu Link opens in a new window Library logo Prolib Integro - home pageUniwersytet Ekonomiczny we Wrocławiu

You search for a phrase ""Vaccines, Synthetic"" according to the criterion: Subject Terms

  Filters
Align
Showing 1-20 from 1700 results
Title:
UV-C irradiation as an effective tool for sterilization of porcine chimeric VP1-PCV2bCap recombinant vaccine.
Authors:
Vrablikova A; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic. .
Fojtikova M; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Hezova R; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Simeckova P; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Brezani V; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Strakova N; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Fraiberk M; Faculty of Science, Charles University, Albertov 6, 128 00, Prague, Czech Republic.
Kotoucek J; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Masek J; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Psikal I; Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
Show more
Source:
Scientific reports [Sci Rep] 2023 Nov 07; Vol. 13 (1), pp. 19337. Date of Electronic Publication: 2023 Nov 07.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Vaccines, Synthetic*
Viruses*
Mice ; Animals ; Swine ; Sterilization ; Recombinant Proteins/genetics ; Ultraviolet Rays
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.
Authors:
Hentzien M; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; University of Reims Champagne-Ardenne, Reims, France.
Bonnet F; CHU de Bordeaux, Hôpital Saint-André, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France.; Université de Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, F-33000, France.
Bernasconi E; Department of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Biver E; Division of Bone Diseases, Geneva University Hospitals, Geneva, Switzerland.
Braun DL; Division Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Munting A; Service of Infectious Diseases, Centre Hospitalier Universitaire Vaudoise (CHUV), Lausanne, Switzerland.
Leuzinger K; Clinical Virology, University Hospital Basel, Basel, Switzerland.
Leleux O; Université de Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, F-33000, France.
Musardo S; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
Prendki V; Division of Infectious Disease, Geneva University Hospital, Geneva, Switzerland.
Schmid P; Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital, St Gallen, Switzerland.
Staehelin C; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Stoeckle M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Walti CS; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
Wittkop L; CHU de Bordeaux, Hôpital Saint-André, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France.; CHU de Bordeaux, Service d'information médicale, INSERM, Institut Bergonié, CIC-EC 1401, Bordeaux, F-33000, France.; Inria équipe SISTM team, Talence, France.
Appay V; Université de Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, Bordeaux, 33000, France.
Didierlaurent AM; Department of Pathology and Immunology, Center of Vaccinology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. .
Calmy A; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. .
Show more
Source:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 19; Vol. 24 (1), pp. 329. Date of Electronic Publication: 2024 Mar 19.
Publication Type:
Clinical Trial; Journal Article
MeSH Terms:
Herpes Zoster Vaccine*
Neuralgia, Postherpetic*/prevention & control
HIV Infections*/complications
HIV Infections*/drug therapy
Herpes Zoster*/epidemiology
Humans ; Middle Aged ; Aged ; Quality of Life ; Herpesvirus 3, Human ; Vaccines, Synthetic ; Immunity ; Multicenter Studies as Topic
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
Authors:
Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Dintwe OB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
Omar FL; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Naicker N; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa; and Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Jani I; Instituto Nacional de Saude, Maputo, Mozambique.
Mgodi NM; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Hunidzarira P; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Sebe M; Aurum Institute, Tembisa, Gauteng, South Africa.
Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Polakowski L; DAIDS, NIAID, NIH, Bethesda, Maryland, United States of America.
Ramirez S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Nebergall M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Takuva S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Sikhosana L; Hutchinson Centre Research Institute of South Africa, Johannesburg, South Africa.
Heptinstall J; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
Seaton KE; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
De Rosa S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Diazgranados CA; Formerly Sanofi-Pasteur, Swiftwater, Pennsylvania, Pennsylvania, United States of America.
Koutsoukos M; GSK, Wavre, Belgium.
Van Der Meeren O; Previously GSK, Rixensart, Belgium.
Barnett SW; Bill & Melinda Gates Foundation, Seattle, Washington, United States of America.
Kanesa-Thasan N; Formerly GSK, Rockville, Maryland, United States of America.
Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Tomaras GD; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Mngadi K; Aurum Institute, Tembisa, Gauteng, South Africa.
Goepfert P; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Show more
Corporate Authors:
HVTN 107 Protocol Team
Source:
PLoS medicine [PLoS Med] 2024 Mar 19; Vol. 21 (3), pp. e1004360. Date of Electronic Publication: 2024 Mar 19 (Print Publication: 2024).
Publication Type:
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
MeSH Terms:
AIDS Vaccines*/adverse effects
Alum Compounds*
HIV Infections*/prevention & control
HIV-1*
Polysorbates*
Squalene*
Adult ; Humans ; Adjuvants, Immunologic ; HIV Antibodies ; Immunogenicity, Vaccine ; Immunoglobulin A ; Immunoglobulin G ; Vaccines, Combined ; Vaccines, Synthetic
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor.
Authors:
Kim JY; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.; Department of Biomedical Science, Graduate School, Catholic University of Daegu, Daegu 38430, Republic of Korea.
Park SY; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Lee G; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Park SH; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Jin JS; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Kim D; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Park JH; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Jeong SY; Department of Biomedical Science, Graduate School, Catholic University of Daegu, Daegu 38430, Republic of Korea.
Ko YJ; Animal and Plant Quarantine Agency, Gimcheon-si 39660, Republic of Korea.
Show more
Source:
Viruses [Viruses] 2024 Mar 16; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 16.
Publication Type:
Journal Article
MeSH Terms:
Foot-and-Mouth Disease*
Foot-and-Mouth Disease Virus*
Viral Vaccines*
Animals ; Swine ; Virus Inactivation ; Capsid Proteins ; Vaccines, Synthetic ; Bioreactors
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Novel Universal Recombinant Rotavirus A Vaccine Candidate: Evaluation of Immunological Properties.
Authors:
Granovskiy DL; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Khudainazarova NS; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Evtushenko EA; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Ryabchevskaya EM; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Kondakova OA; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Arkhipenko MV; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Kovrizhko MV; Rostov Research Institute of Microbiology and Parasitology, 344010 Rostov-On-Don, Russia.
Kolpakova EP; Rostov Research Institute of Microbiology and Parasitology, 344010 Rostov-On-Don, Russia.
Tverdokhlebova TI; Rostov Research Institute of Microbiology and Parasitology, 344010 Rostov-On-Don, Russia.
Nikitin NA; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Karpova OV; Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Show more
Source:
Viruses [Viruses] 2024 Mar 12; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 12.
Publication Type:
Journal Article
MeSH Terms:
Rotavirus*/genetics
Rotavirus Infections*
Gastroenteritis*/prevention & control
Rotavirus Vaccines*/genetics
Animals ; Mice ; Child ; Humans ; Child, Preschool ; Prospective Studies ; Antibodies, Viral ; Vaccines, Synthetic/genetics
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Recombinant production of SAG1 fused with xylanase in Pichia pastoris induced higher protective immunity against Eimeria tenella infection in chicken.
Authors:
Liu C; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Wei H; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Liang R; Key Laboratory of Animal Biosafety Risk Prevention and Control (North) of MARA, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Wang Y; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Su X; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Tu T; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Luo H; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Yao B; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Ding J; Key Laboratory of Animal Biosafety Risk Prevention and Control (North) of MARA, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Tang X; Key Laboratory of Animal Biosafety Risk Prevention and Control (North) of MARA, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Huang H; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Zhang H; State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Show more
Source:
Microbial biotechnology [Microb Biotechnol] 2024 Mar; Vol. 17 (3), pp. e14447.
Publication Type:
Journal Article
MeSH Terms:
Eimeria tenella*/genetics
Coccidiosis*/prevention & control
Coccidiosis*/veterinary
Saccharomycetales*
Animals ; Chickens ; Antigens, Surface ; Antigens, Protozoan/genetics ; Recombinant Proteins/genetics ; Vaccines, Synthetic/genetics
SCR Organism:
Komagataella pastoris
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Deletion of the EP402R Gene from the Genome of African Swine Fever Vaccine Strain ASFV-G-∆I177L Provides the Potential Capability of Differentiating between Infected and Vaccinated Animals.
Authors:
Borca MV; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Ramirez-Medina E; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Espinoza N; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Rai A; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN 37830, USA.
Spinard E; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Velazquez-Salinas L; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Valladares A; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN 37830, USA.
Silva E; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Burton L; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Meyers A; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN 37830, USA.
Clark J; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Wu P; Plum Island Animal Disease Center, U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Orient, NY 11957, USA.
Gay CG; Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705, USA.
Gladue DP; Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, U.S. Department of Agriculture, Agricultural Research Service, Orient, NY 11957, USA.; Foreign Animal Disease Research Unit, U.S. Department of Agriculture, Agricultural Research Service, National Bio and Agro-Defense Facility, Manhattan, KS 66502, USA.
Show more
Source:
Viruses [Viruses] 2024 Feb 28; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 28.
Publication Type:
Journal Article
MeSH Terms:
African Swine Fever Virus*
African Swine Fever*
Viral Vaccines*/genetics
Swine ; Animals ; Sus scrofa ; Virulence ; Vaccines, Synthetic/genetics ; Vaccines, Attenuated/genetics ; Recombinant Proteins/genetics ; Gene Deletion
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection.
Authors:
Zhang F; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China.
Ni L; College of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China.
Zhang Z; Department of Geriatrics and Special Needs Medicine, General Hospital of Ningxia Medical University, Yinchuan, 750004, China.
Luo X; Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Wang X; Key Laboratory of Radiation Oncology of Taizhou, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, 317000, China.
Zhou W; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.
Chen J; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.
Liu J; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China.
Qu Y; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China. .
Liu K; College of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China. .; Ningxia Key Laboratory of Cerebrocranial Diseases, Ningxia Medical University, Yinchuan, 750004, China. .
Guo L; College of First Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China. .; College of Laboratory Medicine , Ningxia Medical University, Yinchuan, 750004, China. .; Ningxia Key Laboratory of Cerebrocranial Diseases, Ningxia Medical University, Yinchuan, 750004, China. .; Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, 750004, China. .
Show more
Source:
Microbial cell factories [Microb Cell Fact] 2024 Feb 24; Vol. 23 (1), pp. 61. Date of Electronic Publication: 2024 Feb 24.
Publication Type:
Journal Article
MeSH Terms:
Helicobacter pylori*
Animals ; Mice ; Immunity, Mucosal ; Virulence Factors ; Bacterial Vaccines ; Urease ; Vaccines, Synthetic ; Mice, Inbred BALB C ; Administration, Oral
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and Children.
Authors:
Karron RA; Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Herbert K; Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Wanionek K; Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Schmidt AC; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.; Present Affiliation: Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA.
Schaap-Nutt A; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
Collins PL; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
Buchholz UJ; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
Show more
Source:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2023 Apr 18; Vol. 12 (3), pp. 173-176.
Publication Type:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Parainfluenza Virus 2, Human*
Vaccines, Synthetic*
Adult ; Child ; Humans ; Antibodies, Viral ; Parainfluenza Virus 1, Human ; Parainfluenza Virus 3, Human ; Vaccines, Attenuated
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.
Authors:
Arevalo CP; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Bolton MJ; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Le Sage V; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Ye N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Furey C; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Muramatsu H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Alameh MG; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Pardi N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Drapeau EM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Parkhouse K; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Garretson T; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Morris JS; Department of Biostatistics Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Moncla LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Tam YK; Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada.
Fan SHY; Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada.
Lakdawala SS; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Weissman D; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Hensley SE; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Show more
Source:
Science (New York, N.Y.) [Science] 2022 Nov 25; Vol. 378 (6622), pp. 899-904. Date of Electronic Publication: 2022 Nov 24.
Publication Type:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Orthomyxoviridae Infections*/prevention & control
Vaccines, Combined*/genetics
Vaccines, Combined*/immunology
mRNA Vaccines*/genetics
mRNA Vaccines*/immunology
Vaccines, Synthetic*/genetics
Vaccines, Synthetic*/immunology
Influenza A virus*/immunology
Influenza B virus*/immunology
Animals ; Mice ; Ferrets ; Nucleosides/chemistry ; Nucleosides/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/immunology ; Cross Reactions
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
The influenza universe in an mRNA vaccine.
Authors:
Kelvin AA; Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.; Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Falzarano D; Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Saskatchewan, Canada.; Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Show more
Source:
Science (New York, N.Y.) [Science] 2022 Nov 25; Vol. 378 (6622), pp. 827-828. Date of Electronic Publication: 2022 Nov 24.
Publication Type:
Journal Article; Comment
MeSH Terms:
Influenza B virus*/immunology
Influenza Vaccines*/genetics
Influenza Vaccines*/immunology
Influenza, Human*/prevention & control
mRNA Vaccines*/genetics
mRNA Vaccines*/immunology
Vaccines, Synthetic*/genetics
Vaccines, Synthetic*/immunology
Alphainfluenzavirus*/immunology
Animals ; Mice ; Ferrets
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virus.
Authors:
Kapczynski DR; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.
Chrzastek K; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.
Shanmugasundaram R; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.
Zsak A; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.
Segovia K; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.
Sellers H; Department of Population Health, College of Veterinary Medicine, The University of Georgia, 956 College Station Road, 30602, Athens, Athens, GA, U.S.
Suarez DL; Exotic and Emerging Avian Viral Diseases Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, 934 College Station Road, 30605, Athens, GA, U.S.. .
Show more
Source:
Virology journal [Virol J] 2023 Dec 15; Vol. 20 (1), pp. 298. Date of Electronic Publication: 2023 Dec 15.
Publication Type:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza A Virus, H5N2 Subtype*/genetics
Influenza in Birds*
Influenza A virus*
Animals ; Chickens ; Vaccines, Synthetic ; Hemagglutinin Glycoproteins, Influenza Virus/genetics
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8.
Authors:
Watanabe S; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Yoshikawa T; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Kaku Y; Division of Veterinary Science, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Kurosu T; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Fukushi S; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Sugimoto S; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Nishisaka Y; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Fuji H; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Marsh G; Australian Centre for Disease Preparedness, CSIRO, Geelong, VIC, Australia.
Maeda K; Division of Veterinary Science, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Ebihara H; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Morikawa S; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Shimojima M; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Saijo M; Department of Virology I, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.; Public Health Office, Health and Welfare Bureau, Sapporo Municipal Government, Sapporo, Hokkaido, Japan.
Show more
Source:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Dec 15; Vol. 17 (12), pp. e0011851. Date of Electronic Publication: 2023 Dec 15 (Print Publication: 2023).
Publication Type:
Journal Article
MeSH Terms:
Nipah Virus*/genetics
Viral Vaccines*/genetics
Henipavirus Infections*/prevention & control
Animals ; Cricetinae ; Humans ; Vaccinia virus/genetics ; Glycoproteins/genetics ; Glycoproteins/metabolism ; Vaccines, Synthetic/genetics
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Evaluation of a new fusion antigen, cd loop and HAP2-GCS1 domain (cd-HAP) of Plasmodium falciparum Generative Cell Specific 1 antigen formulated with various adjuvants, as a transmission blocking vaccine.
Authors:
Pourhashem Z; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Nourani L; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Sani JJ; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Yousefi H; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Pirahmadi S; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Sabouri M; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Raz A; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Djadid ND; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Zakeri S; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran. .
Mehrizi AA; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran. .
Show more
Source:
Malaria journal [Malar J] 2023 Dec 09; Vol. 22 (1), pp. 374. Date of Electronic Publication: 2023 Dec 09.
Publication Type:
Journal Article
MeSH Terms:
Malaria Vaccines*
Malaria, Falciparum*
Animals ; Mice ; Adjuvants, Immunologic ; Adjuvants, Pharmaceutic ; Antibodies, Protozoan ; Antigens, CD ; Antigens, Protozoan ; Immunoglobulin G ; Iran ; Oocysts ; Plasmodium falciparum ; Protozoan Proteins/metabolism ; Vaccines, Synthetic ; Humans
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Oral Immunization with Attenuated Salmonella Choleraesuis Expressing the FedF Antigens Protects Mice against the Shiga-Toxin-Producing Escherichia coli Challenge.
Authors:
Zhang G; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.
Fu Y; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.
Li Y; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.
Li Q; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.
Wang S; Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32611-0880, USA.
Shi H; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.; Joint International Research Laboratory of Agriculture and Agri-Product Safety, Yangzhou University (JIRLAAPS), Yangzhou 225009, China.
Show more
Source:
Biomolecules [Biomolecules] 2023 Nov 30; Vol. 13 (12). Date of Electronic Publication: 2023 Nov 30.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Shiga-Toxigenic Escherichia coli*/genetics
Salmonella enterica*
Escherichia coli Infections*
Salmonella Vaccines*
Animals ; Mice ; Swine ; Salmonella ; Vaccines, Synthetic/genetics ; Immunization
SCR Organism:
Salmonella enterica subsp. enterica
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Plant-based production of a protective vaccine antigen against the bovine parasitic nematode Ostertagia ostertagi.
Authors:
Zwanenburg L; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
Borloo J; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
Decorte B; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
Bunte MJM; Laboratory of Nematology, Department of Plant Sciences, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Mokhtari S; Laboratory of Nematology, Department of Plant Sciences, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Serna S; Glycotechnology Laboratory, Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramon 194, 20014, Donostia San Sebastián, Spain.; CIBER-BBN, Paseo Miramón 194, 20014, San Sebastian, Spain.
Reichardt NC; Glycotechnology Laboratory, Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramon 194, 20014, Donostia San Sebastián, Spain.; CIBER-BBN, Paseo Miramón 194, 20014, San Sebastian, Spain.
Seys LJM; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
van Diepen A; Department of Parasitology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Schots A; Laboratory of Nematology, Department of Plant Sciences, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Wilbers RHP; Laboratory of Nematology, Department of Plant Sciences, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Hokke CH; Department of Parasitology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Claerebout E; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium.
Geldhof P; Laboratory of Parasitology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820, Merelbeke, Belgium. .
Show more
Source:
Scientific reports [Sci Rep] 2023 Nov 22; Vol. 13 (1), pp. 20488. Date of Electronic Publication: 2023 Nov 22.
Publication Type:
Journal Article
MeSH Terms:
Ostertagiasis*/prevention & control
Ostertagiasis*/veterinary
Cattle Diseases*
Cattle ; Animals ; Ostertagia/genetics ; Vaccination/veterinary ; Vaccines, Synthetic/genetics ; Recombinant Proteins/genetics ; Parasite Egg Count
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.
Authors:
Le T; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Sun C; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Chang J; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Zhang G; Departments of Animal Science, School of Agriculture, Ningxia University, Yinchuan 750021, China.
Yin X; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Show more
Source:
Viruses [Viruses] 2022 Feb 15; Vol. 14 (2). Date of Electronic Publication: 2022 Feb 15.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Communicable Disease Control*
Communicable Diseases/*virology
Communicable Diseases, Emerging/*prevention & control
Vaccines, Synthetic/*genetics
Vaccines, Synthetic/*immunology
Zoonoses/*prevention & control
mRNA Vaccines/*genetics
mRNA Vaccines/*immunology
Animals ; Communicable Diseases/classification ; Communicable Diseases, Emerging/immunology ; Humans ; Vaccines, Synthetic/analysis ; Vaccines, Synthetic/classification ; Zoonoses/immunology ; Zoonoses/transmission ; mRNA Vaccines/analysis ; mRNA Vaccines/classification
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White Rabbits.
Authors:
Awasthi M; Tonix Pharmaceutical, Frederick, MD 21701, USA.
Macaluso A; Tonix Pharmaceutical, Frederick, MD 21701, USA.
Goebel SJ; Tonix Pharmaceutical, Frederick, MD 21701, USA.
Luea E; Southern Research, Birmingham, AL 35205, USA.
Noyce RS; Department of Medical Microbiology & Immunology, Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Nasar F; Tonix Pharmaceutical, Frederick, MD 21701, USA.
Daugherty B; Tonix Pharmaceuticals, Chatham, NJ 07928, USA.
Bavari S; Tonix Pharmaceutical, Frederick, MD 21701, USA.
Lederman S; Tonix Pharmaceuticals, Dartmouth, MA 02745, USA.
Show more
Source:
Viruses [Viruses] 2023 Oct 21; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 21.
Publication Type:
Journal Article
MeSH Terms:
COVID-19*
Poxviridae*
Cricetinae ; Rabbits ; Animals ; Mesocricetus ; SARS-CoV-2/genetics ; Vaccines, Attenuated/adverse effects ; Vaccines, Synthetic/adverse effects ; Vaccines, Synthetic/genetics ; Antibodies, Viral ; Immunoglobulin G ; Spike Glycoprotein, Coronavirus/genetics ; Antibodies, Neutralizing
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Protective efficacy of six recombinant proteins as vaccine candidates against Echinococcus granulosus in dogs.
Authors:
Shao G; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Hua R; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Song H; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Chen Y; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Zhu X; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Hou W; Sichuan Center for Animal Disease Prevention and Control, Chengdu, Sichuan Province, P. R. China.
Li S; Sichuan Center for Animal Disease Prevention and Control, Chengdu, Sichuan Province, P. R. China.
Yang A; Sichuan Center for Animal Disease Prevention and Control, Chengdu, Sichuan Province, P. R. China.
Yang G; Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan Province, P. R. China.
Show more
Source:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Oct 23; Vol. 17 (10), pp. e0011709. Date of Electronic Publication: 2023 Oct 23 (Print Publication: 2023).
Publication Type:
Journal Article
MeSH Terms:
Echinococcus granulosus*/genetics
Echinococcosis*/prevention & control
Echinococcosis*/veterinary
Dog Diseases*/prevention & control
Dog Diseases*/parasitology
Dogs ; Animals ; Vaccines, Synthetic/genetics ; Recombinant Proteins/genetics ; Immunoglobulin G
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Advances of Reverse Vaccinology for mRNA Vaccine Design against SARS-CoV-2: A Review of Methods and Tools.
Authors:
da Silva MK; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Campos DMO; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Akash S; Department of Pharmacy, Daffodil International University, Sukrabad, Dhaka 1207, Bangladesh.
Akter S; Bangladesh Council of Scientific & Industrial Research (BCSIR), Dhaka 1205, Bangladesh.
Yee LC; Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Kota Bharu 11800, Kelantan, Malaysia.
Fulco UL; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Oliveira JIN; Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal 59064-741, RN, Brazil.
Show more
Source:
Viruses [Viruses] 2023 Oct 21; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 21.
Publication Type:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
SARS-CoV-2*/genetics
COVID-19*/prevention & control
Humans ; COVID-19 Vaccines ; Vaccinology/methods ; Proteomics ; mRNA Vaccines ; Vaccines, Synthetic
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Showing 1-20 from 1700 results

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.